Sofia

Futó vizsgálatok

• Fut, nem toboroz

  An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

  NCT07517263· 3. fázis· Forrás

• Toboroz

  Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia

  NCT07467993· 2. fázis· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  NCT07225504· 3. fázis· Forrás

• Fut, nem toboroz

  Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis

  NCT07220577· 2. fázis· Forrás

• Fut, nem toboroz

  An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis

  NCT07029555· 1. fázis· Forrás

• Fut, nem toboroz

  A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

  NCT05739383· 3. fázis· Forrás

• Fut, nem toboroz

  Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

  NCT05030428· 3. fázis· Forrás

• Fut, nem toboroz

  Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS

  NCT03650114· 3. fázis· Forrás

• Fut, nem toboroz

  CINC424A2X01B Rollover Protocol

  NCT02386800· 4. fázis· Forrás

• Fut, nem toboroz

  Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis

  NCT01892722· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Sclerosis multiplex (SM)1 toboroz
• Skizofrénia1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients.

  NCT05562934· 2. fázis· Forrás

• Lezárult

  Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia

  NCT05192941· 4. fázis· Forrás

• Lezárult

  Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

  NCT04023552· 3. fázis· Forrás

• Lezárult

  Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer

  NCT03822468· 2. fázis· Forrás

• Lezárult

  Open-label Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HF

  NCT03785405· 3. fázis· Forrás

• Leállították

  A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma

  NCT02967692· 3. fázis· Forrás